23andMe Holding Co. today filed for bankruptcy. The company, which sells saliva-based genetic testing kits for consumers, will continue operating during the Chapter 11 proceedings. It plans to ...

Cutera (NASDAQ:CUTR) has filed for Chapter 11 bankruptcy protection in the Southern District of Texas as it takes steps to strengthen its financial position. The aesthetics device company has ...

Bar Louie, a Texas-based restaurant chain, has filed for Chapter 11 bankruptcy protection, according to reports. The news comes as the chain recently closed 14 restaurants in Tennessee ...

23andMe made a name for itself by selling at-home, mail-in DNA testing kits ... 23andMe ultimately filed for Chapter 11 bankruptcy protection in late March, saying it hopes the move will help ...

After the devastating path COVID tore through nursing homes, many experts pushed to have ... infuse state and local health departments with $11.4 billion this fiscal year. But the Department ...

South Texas Health System McAllen told FOX Weather that they remain open Friday and continue providing care to patients. On Thursday, the facility experienced minor flooding on the first floor due ...

The genetic testing company 23andMe has filed for Chapter 11 bankruptcy, raising concerns about the security of customer genetic data, according to the Associated Press. Despite the bankruptcy ...

23andMe, one of the "leading human genetics and biotechnology companies," announced that it has filed for bankruptcy ... started voluntarily filing for Chapter 11 Bankruptcy in the U.S. Bankruptcy ...

23andMe has filed for Chapter 11 bankruptcy protection and its co-founder and CEO has resigned as the struggling genetic testing company continues its push to cut costs 23andMe has filed for ...

According to the United States Courts, Chapter 11 bankruptcy is frequently referred to as a "reorganization" bankruptcy. "Usually, the debtor remains 'in possession,' has the powers and duties of ...

NEW YORK (AP) — 23andMe has filed for Chapter 11 bankruptcy protection and its co-founder and CEO has resigned as the struggling genetic testing company continues its push to cut costs.